Cargando…
Pulmonary artery pressure‐guided heart failure management: US cost‐effectiveness analyses using the results of the CHAMPION clinical trial
AIMS: Haemodynamic‐guided heart failure (HF) management effectively reduces decompensation events and need for hospitalizations. The economic benefit of clinical improvement requires further study. METHODS AND RESULTS: An estimate of the cost‐effectiveness of haemodynamic‐guided HF management was ma...
Autores principales: | Martinson, Melissa, Bharmi, Rupinder, Dalal, Nirav, Abraham, William T., Adamson, Philip B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434920/ https://www.ncbi.nlm.nih.gov/pubmed/27647784 http://dx.doi.org/10.1002/ejhf.642 |
Ejemplares similares
-
The cost‐effectiveness of real‐time pulmonary artery pressure monitoring in heart failure patients: a European perspective
por: Cowie, Martin R., et al.
Publicado: (2017) -
Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022) -
Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real‐world population
por: Zile, Michael R., et al.
Publicado: (2020) -
Assessment of Association Between Venous Occlusion and Infection of Cardiac Implantable Electronic Devices
por: Keyser, Andreas, et al.
Publicado: (2021) -
Association between Arrhythmia and Pulmonary Artery Pressure in Heart Failure Patients Implanted with a Cardiac Defibrillator and Ambulatory Pulmonary Artery Pressure Sensor
por: Doshi, Rahul N., et al.
Publicado: (2019)